Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Effect of Oxygen Levels on the Biological Response of DNA Damage Inhibitors

Overcoming the Hypoxic Barrier to Enhance DNA Damage

Chromosome Breaks and Genome Stability

The aim of the Chromosome Integrity Group is to understand how genome stability is maintained in response to chromosomal breaks.

Protein Degradation In Cellular Response to Ionising Radiation

Investigating the importance of protein turnover in the DNA Damage Response.

The role E3 ubiquitin ligases in cancer pathogenesis and treatment with Ionising Radiation (IR)

Deciphering the role of E3 ubiquitin ligases in the pathogenesis and radiotherapy response of cancers.

Mechanistic Insights for FLASH radiation for clinical use

What is the 'FLASH effect' and how can we use it to cure cancer?

Targeting the innate immune stress response to enhance the therapeutic index of radiotherapy

Understanding how tumours exploit innate immune pathways to their advantage, and how we can target these to improve radiotherapy.

MAFF-mediated transcription regulation of redox pathways in response to radiation treatment

Determining how microenvironments affect tumour progression and radiation responses.

Affiliate programme - Development of therapeutic radiosensitising compounds

Identifying and developing clinically exploitable treatments to widen the therapeutic window of radiotherapy.

Affiliate programme - Biological response to tumour hypoxia

Investigating the biological response to tumour hypoxia and specifically, the levels of hypoxia most associated with radiation resistance.